mometasone receives marketing approval in japan
Post on 09-Dec-2016
212 Views
Preview:
TRANSCRIPT
Inpharma 1648 - 26 Jul 2008
■ Mometasone receives marketing approval in Japanfor the treatment of allergic rhinitis in adults.Mometasone [Nasonex; Schering-Plough], anintranasal steroid, is currently approved in more than100 counties worldwide.Schering-Plough Corporation. NASONEX(R) Now Approved in Japan for theTreatment of Allergic Rhinitis in Adult Patients. Media Release : 17 Jul 2008.Available from: URL: http://www.schering-plough.com 809091111
1
Inpharma 26 Jul 2008 No. 16481173-8324/10/1648-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved
top related